Conferences
2–3 February 2022, Online
10th Advances Against Aspergillosis and Mucormycosis (AAAM-2022)
Dear Respected Academics and Researchers,
On behalf of the Organizing Committee, we are pleased to announce that the 10th Advances Against Aspergillosis and Mucormycosis (AAAM-2022) conference will be virtual only and held on 2–3 February, 2022.
This conference has now clearly established itself as the premier forum for detailed and dedicated discussion of all aspects of Aspergillus infection and research. Beginning with the eighth conference, we have expanded to now include scientific sessions on mucormycosis pathogenesis, diagnosis and treatment. We are holding a virtual event with speakers, posters and abstracts displayed online.
The field of Aspergillus continues in a state of rapid advancement, including the publication of numerous post-genomic papers and substantial advances in translational, immunologic, epidemiologic and diagnostic research. The field of mucormycosis is similarly advancing, with novel studies on pathogenesis and diagnostic options. The launch of several antifungals in the last few years and anticipated clinical trials of newer compounds with novel mechanisms of action cause this to be an exciting time for mycology. Pan-azole and echinocandin Aspergillus resistance has emerged and requires unique approaches; combination therapy remains an important area of interest for both aspergillosis and mucormycosis. Greatly increased awareness of allergic aspergillosis has opened new opportunities for both antifungal agents and immunotherapies. New molecular strategies for diagnosis continue to make progress, and recent guidelines offer increased diagnostic insight. There is a continuing high death toll from invasive aspergillosis and mucormycosis, including patient groups not usually associated with this opportunistic infection. This meeting is another chance to gather the world’s aspergillosis and mucormycosis experts in one venue. A fundamental tenet of this colloquium continues to be to engender collaborative relationships amongst clinicians, scientists and industry to further advance the field.
You can find more information about this event on the webpage of AAAM-2022: https://aaam2022.org/
When this 10th meeting convenes, it will represent the 20th year of Advances Against Aspergillosis activity, beginning with the initial supplement in Clinical Infectious Diseases that originated in 2002.
With our best regards,
Organizing Committee of AAAM-2022
